Tackling population health challenges means asking big questions, such as:
And how do you even know which are the right questions to ask?
Our simulation and analysis expertise turns tomorrow’s population health questions and challenges into today’s focussed, specific, actionable decisions.
We can help you understand and explore those questions and challenges far into the future. Our scenario modelling will show you how different kinds of health interventions, drug innovations and policy changes can impact them.
And that will help you choose the best way forward.
Deep expertise in modelling non-communicable diseases, combined with entrepreneurial vision.Why Us?
We’ve created a specific process to help you find, ask and answer the right questions.Method
We’ve answered many different kinds of questions for many different organisations in over 70 countries.Track Record
We have an experienced and multi-disciplinary team of software engineers, population health and policy research experts, and mathematicians.Team
We all know that too much salt is bad for our health! Consuming too much salt can lead to high blood pressure which can lead to a variety of different health conditions including stroke and coronary heart disease. These diseases combined, claim the lives of millions of people globally, and costs the NHS, as well […]Read
Of the three main phases of clinical trials, by far the most expensive part of the process is the Phase 3 trial, typically requiring from several hundred to several thousand participants and costing up to $20 million on average. Furthermore, the process is fraught with risks with up to 70% of Phase 2 trials and […]Read
Obesity is increasing across Europe and, together with alcohol consumption, is contributing to rising rates of chronic liver diseases, and related conditions [1,2,3]; alcoholic liver disease will shortly overtake ischaemic heart disease in the number of years of working life lost (3). Quantifying the epidemiological and economic burden of obesity and alcohol-related conditions is essential […]Read
Today, Cancer Research UK has published a new report ‘Making Conversations Count for All: Benefits of improving delivery of smoking cessation interventions for different socioeconomic groups’ which includes modelling conducted by HealthLumen. This builds on the previous 2020 report, which aimed to estimate the burden of active smoking related disease in the UK and quantify the health and economic […]Read